We have previously shown that mIDH-R132H, in the context of ATRX and TP53 inactivation, epigenetically reprograms gene regions corresponding to DNA repair proteins in human and murine glioma cell cultures (44). This evidence concerns the gene ATRX and central nervous system cancer.